Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway
Authors
Keywords
-
Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 192, Issue -, Pages 25-36
Publisher
Elsevier BV
Online
2022-09-10
DOI
10.1016/j.freeradbiomed.2022.08.037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosomes Derived from Baicalin-Pretreated Mesenchymal Stem Cells Alleviate Hepatocyte Ferroptosis after Acute Liver Injury via the Keap1-NRF2 Pathway
- (2022) Shuxian Zhao et al. Oxidative Medicine and Cellular Longevity
- Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
- (2021) Johanna C. Arroyave-Ospina et al. Antioxidants
- Extracellular vesicles derived from Mesenchymal Stem/Stromal Cells: the regenerative impact in liver diseases
- (2021) Adriana Psaraki et al. HEPATOLOGY
- Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality
- (2021) Tracey G. Simon et al. JOURNAL OF HEPATOLOGY
- Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression
- (2021) Lidan Cheng et al. Human Cell
- hPMSCs-Derived Exosomal miRNA-21 Protects Against Aging-Related Oxidative Damage of CD4+ T Cells by Targeting the PTEN/PI3K-Nrf2 Axis
- (2021) Yanlian Xiong et al. Frontiers in Immunology
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p
- (2020) Mingyang Shao et al. Stem Cell Research & Therapy
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy
- (2020) Qin He et al. Stem Cell Research & Therapy
- Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Protect Liver Ischemia/Reperfusion Injury by Reducing CD154 Expression on CD4+ T Cells via CCT2
- (2020) Jun Zheng et al. Advanced Science
- Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway
- (2019) Xiaoli Rong et al. Stem Cell Research & Therapy
- Mesenchymal stem cell-derived exosomes for clinical use
- (2019) Mayela Mendt et al. BONE MARROW TRANSPLANTATION
- MiR‐20a‐containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia/reperfusion injury
- (2019) Lin Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
- (2019) Valerio Rosato et al. International Journal of Environmental Research and Public Health
- HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis
- (2019) Stefania Bruno et al. MOLECULAR THERAPY
- Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
- (2018) Yaoxiang Sun et al. ACS Nano
- Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages
- (2018) Linrui Jiang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation
- (2018) Shikha Mohan et al. BIOMEDICINE & PHARMACOTHERAPY
- HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization
- (2018) Qiuyue Kong et al. DIABETES
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Nrf2, the Master Regulator of Anti-Oxidative Responses
- (2017) Sandra Vomund et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
- (2017) Daniel Garcia et al. MOLECULAR CELL
- hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury
- (2017) Yongmin Yan et al. MOLECULAR THERAPY
- AMPK as a Therapeutic Target for Treating Metabolic Diseases
- (2017) Emily A. Day et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis
- (2017) Jinghua Du et al. Theranostics
- Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
- (2017) Laura Vergani CURRENT MEDICINAL CHEMISTRY
- Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH)
- (2015) Aastha Jindal et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice
- (2013) Chunfen Mo et al. ANTIOXIDANTS & REDOX SIGNALING
- Nrf2 affects the efficiency of mitochondrial fatty acid oxidation
- (2013) Marthe H. R. Ludtmann et al. BIOCHEMICAL JOURNAL
- Regulation of Nrf2—an update
- (2013) Suryakant K. Niture et al. FREE RADICAL BIOLOGY AND MEDICINE
- CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease
- (2012) Tung-Ming Leung et al. JOURNAL OF HEPATOLOGY
- Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
- (2012) Sadagopan Magesh et al. MEDICINAL RESEARCH REVIEWS
- NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet
- (2008) Y. Tanaka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started